Occipital Nerve Stimulation for Refractory Chronic Cluster Headache: A Cost ‐Effectiveness Study
ConclusionConsidering the burden of rCCH and the efficacy and safety of ONS, the demonstration that ONS is dominant should help its diffusion, validation, and reimbursement by health authorities in this severely disabled population.
Source: Neuromodulation: Technology at the Neural Interface - Category: Biotechnology Authors: Julie Bulsei,
Aur élie Leplus,
Anne Donnet,
Jean Regis,
Christian Lucas,
Nadia Buisset,
Sylvie Raoul,
Evelyne Guegan‐Massardier,
Stéphane Derrey,
Bechir Jarraya,
Dominique Valade,
Caroline Roos,
Christelle Creach,
Stéphan Chabardes,
Pie Tags: Clinical Research Source Type: research
More News: Biotechnology | Brain | Disability | France Health | Headache | Migraine | Neurology | Study